1991
DOI: 10.1097/00005344-199100001-00042
|View full text |Cite
|
Sign up to set email alerts
|

Nitric Oxide Release in Response to Stimulation of Nonadrenergic, Noncholinergic Nerves

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
9
0

Year Published

1992
1992
2010
2010

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 0 publications
1
9
0
Order By: Relevance
“…These responses are eliminated by supplementation of L-but not D-arginine (Gold et al 1989;Ress et al 1989). Introduction of NOS inhibitors (Palmer et al 1988) greatly contributed to clarifying the physiological roles of NO not only in the endothelium and vasculature but also in the immune system, the gastric mucosa (Lanas 2008), in the central (Garthwaite et al 1988) and peripheral nervous system, namely in the nonadrenergic-noncholinergic (NANC) inhibitory transmission in gut, airways, lower urinary tract, corpora cavernosa and some blood vessels (Boeckstaens et al 1990;Bauer 1993;Lefebvre 1995;Toda and Okamura 2003;Toda and Herman 2005).…”
Section: No Synthasementioning
confidence: 99%
“…These responses are eliminated by supplementation of L-but not D-arginine (Gold et al 1989;Ress et al 1989). Introduction of NOS inhibitors (Palmer et al 1988) greatly contributed to clarifying the physiological roles of NO not only in the endothelium and vasculature but also in the immune system, the gastric mucosa (Lanas 2008), in the central (Garthwaite et al 1988) and peripheral nervous system, namely in the nonadrenergic-noncholinergic (NANC) inhibitory transmission in gut, airways, lower urinary tract, corpora cavernosa and some blood vessels (Boeckstaens et al 1990;Bauer 1993;Lefebvre 1995;Toda and Okamura 2003;Toda and Herman 2005).…”
Section: No Synthasementioning
confidence: 99%
“…The reduction in salivary flow in response to sympathetic stimulation following the administration of propranolol may also reflect the effect of the drug on the blood flow, at least in part, and likewise following administration of L-NAME, as Schachter et al (1991) (Liu, Crawley, Evans & Barnes, 1991); the present results indicate that this is likely to occur under physiological conditions. Evidence has been presented recently which strongly suggests that EDRF is released from certain populations of nerve terminals both centrally (Garthwaite, Charles & Chess-Williams, 1988) and peripherally (Gillespie, Liu & Martin, 1989;Boeckxstaens, Bult, Pelckmans, Jordaens, De Man, Herman & Van Maercke, 1991;Hollywood, Thornbury & McHale, 1992). However, this is unlikely to be the case in the sympathetic nerves of the submandibular glands in the cat, since the residual vasodilator response to stimulation of the sympathetic innervation following treatment with propranolol was abolished by dihydroergotamine (Bloom et al 1987).…”
Section: A V Edwards and J R Garrettmentioning
confidence: 99%
“…First ATP and then VIP, were regarded as putative neurotransmitters in the gut (Burnstock et al, 1978;Manzini et al, 1986;Grider & Makhlouf, 1988). More recently, nitric oxide (NO) has been viewed as the main NANC inhibitory neurotransmitter in the gastrointestinal tract of many species (Boeckxstaens et al, 1991;Burleigh, 1992;Suthamnatpong et al, 1994;Serio et al, 1995;Takeuchi et al, 1996). However, it has become evident that IJPs may often show two phases, a fast and a slow hyperpolarization.…”
Section: Introductionmentioning
confidence: 99%